Role of anti-DFS70 antibodies in ruling out connective tissue disorders in Antinuclear Antibody (ANA) positive patients: A Cross-Sectional Study.

Sanjeet  Kumar; Ravi Ranjan Kumar  Suman; Rajeev Ranjan; Rajneesh  Kumar

doi:10.51168/sjhrafrica.v6i9.2102

Authors

Sanjeet Kumar Senior Resident, Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, India
Ravi Ranjan Kumar Suman Senior Resident, Department of Biochemistry, All India Institute of Medical Sciences, Patna, India
Rajeev Ranjan Senior Resident, Department of Biochemistry, All India Institute of Medical Sciences, Patna, India
Rajneesh Kumar Senior Resident, Department of Biochemistry, All India Institute of Medical Sciences, Patna, India

DOI:

https://doi.org/10.51168/sjhrafrica.v6i9.2102

Keywords:

Connective Tissue Disorder, Anti-DFS70 antibodies, connective tissue disorders, Antinuclear antibodies, Diagnostics

Abstract

Background

Proteins are the target of Antinuclear Antibodies (ANAs), and the cell nucleus is where most nucleic acid antigens are found. The initial step in laboratory diagnosis for AARD is ANA detection. It is still difficult to comprehend the processes that underlie the production of ANAs in AARD and other chronic diseases of inflammatory.

Objectives

The purpose of conducting this study was to ascertain if isolated anti-DFS70 antibody positivity may be utilized to accurately rule out connective tissue disorders and to assess the value of diagnostics of anti-DFS70 antibodies in those individuals who are ANA-positive.

Materials and Methods

It was a cross-sectional, observational study. The study was carried out in the All-India Institute of Medical Sciences (AIIMS), Patna, Bihar, India. The study was conducted for 13 months. A total of 111 patients were enrolled.

Results

The average age of participants in the group of CTD was 40.1 ± 11.5 years, and CTD group age of participants 37.6 ± 12.6 years. Among all, 82 (73.9%) participants were female, and 29 (26.1%) participants were male. Isolated anti-DFS70 was seen in 16 patients, among them no participant had CTD, and all were non-CTD participants 16 (100%). Anti-DFS70 positive disease specific ENA was observed in 02 participants, and all the patients had CTD.

Conclusion

This study has revealed that isolated anti-DFS70 antibody positivity is quite specific for ruling out connective tissue disorders.

Recommendation

Routine testing for anti-DFS70 antibodies should be included in the diagnostic workup of ANA-positive patients to help effectively distinguish non-CTD cases and prevent unnecessary investigations.

References

Tan EM. Autoantibodies and Autoimmunity: A Three‐Decade Perspective. A Tribute to Henry G. Kunkel a. Annals of the New York Academy of Sciences. 1997 Apr;815(1):1-4. https://doi.org/10.1111/j.1749-6632.1997.tb52040.x

Seelig CA, Bauer O, Seelig HP. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD). Clinical Laboratory. 2016 Jan 1;62(4):499-517. https://doi.org/10.7754/Clin.Lab.2015.150905

Bentow C, Rosenblum R, Correia P, Karayev E, Karayev D, Williams D, Kulczycka J, Fritzler MJ, Mahler M. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies. Lupus. 2016 Jul;25(8):897-904. https://doi.org/10.1177/0961203316641773

Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New England Journal of Medicine. 2003 Oct 16;349(16):1526-33. https://doi.org/10.1056/NEJMoa021933

Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapää-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis research & therapy. 2011 Feb;13:1-8. https://doi.org/10.1186/ar3258

Cheng CF, Lan TY, Shih MC, Li KJ. Monospecific anti-DFS70 antibodies are moderately helpful in excluding ANA-associated rheumatic disease in patients presenting with a dense fine speckled pattern-A systematic review and meta-analysis of diagnostic test accuracy. Autoimmunity reviews. 2020 Oct;19(10):102637. https://doi.org/10.1016/j.autrev.2020.102637

Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. Journal of allergy and clinical immunology. 2000 Jun 1;105(6):1211-20. https://doi.org/10.1067/mai.2000.107039

Ortiz-Hernández GL, Sánchez-Hernández ES, Casiano CA. Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions. Autoimmunity Highlights. 2020 Dec;11(1):3. https://doi.org/10.1186/s13317-020-0126-4

Damoiseaux J, Andrade LE, Fritzler MJ, Herold M, Infantino M, von Muhlen C. Response to 'Titre-specific positive predictive value of anti-nuclear antibody patterns' by Vulsteke et al. Annals of the Rheumatic Diseases. 2021 Aug 1;80(8):e129-. https://doi.org/10.1136/annrheumdis-2019-216266

Leeflang MM, Rutjes AW, Reitsma JB, Hooft L, Bossuyt PM. Variation of a test's sensitivity and specificity with disease prevalence. Cmaj. 2013 Aug 6;185(11):E537-44. https://doi.org/10.1503/cmaj.121286

Leeflang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. Journal of clinical epidemiology. 2009 Jan 1;62(1):5-12. https://doi.org/10.1016/j.jclinepi.2008.04.007